Anthrax Protective Antigen-directed Antibody [EPC] - N0000192703
Pharmacologic Class Information
Pharmacologic Code | N0000192703 |
Pharmacologic Name | Anthrax Protective Antigen-directed Antibody |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Anthrax Protective Antigen-directed Antibody
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Anthrax Protective Antigen-directed Antibody [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
69604-204 | Anthim | Non-Proprietary Name: Obiltoxaximab | Solution | Intravenous | Elusys Therapeutics, Inc. | ACTIVE | |
71655-103 | Raxibacumab | Non-Proprietary Name: Raxibacumab | Injection | Intravenous | Emergent Manufacturing Operations Baltimore Llc | ACTIVE |